Real time application of whole genome sequencing for outbreak investigation - What is an achievable turnaround time?

Whole genome sequencing (WGS) is increasingly employed in clinical settings, though few assessments of turnaround times (TAT) have been performed in real-time. In this study, WGS was used to investigate an unfolding outbreak of vancomycin resistant Enterococcus faecium (VRE) among 3 patients in the ICU of a tertiary care hospital. Including overnight culturing, a TAT of just 48.5 h for a comprehensive report was achievable using an Illumina Miseq benchtop sequencer. WGS revealed that isolates from patient 2 and 3 differed from that of patient 1 by a single nucleotide polymorphism (SNP), indicating nosocomial transmission. However, the unparalleled resolution provided by WGS suggested that nosocomial transmission involved two separate events from patient 1 to patient 2 and 3, and not a linear transmission suspected by the time line. Rapid TAT's are achievable using WGS in the clinical setting and can provide an unprecedented level of resolution for outbreak investigations.

[1]  G. Dougan,et al.  Routine Use of Microbial Whole Genome Sequencing in Diagnostic and Public Health Microbiology , 2012, PLoS pathogens.

[2]  M. Hegde,et al.  Genomic technologies and the new era of genomic medicine. , 2014, The Journal of molecular diagnostics : JMD.

[3]  J. R. Johnson,et al.  Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data , 2013, The Journal of antimicrobial chemotherapy.

[4]  Julian Parkhill,et al.  Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study , 2013, The Lancet. Infectious Diseases.

[5]  Julian Parkhill,et al.  Evolution of MRSA During Hospital Transmission and Intercontinental Spread , 2010, Science.

[6]  James H. Bullard,et al.  Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. , 2011, The New England journal of medicine.

[7]  Shashikant Kulkarni,et al.  Assuring the quality of next-generation sequencing in clinical laboratory practice , 2012, Nature Biotechnology.

[8]  David A. Rasko,et al.  Bacterial genome sequencing in the clinic: bioinformatic challenges and solutions , 2013, Nature Reviews Genetics.

[9]  C. Thermes,et al.  Ten years of next-generation sequencing technology. , 2014, Trends in genetics : TIG.

[10]  F. Baquero,et al.  Global Spread of Vancomycin-resistant Enterococcus faecium from Distinct Nosocomial Genetic Complex , 2005, Emerging infectious diseases.

[11]  Daniel J. Wilson,et al.  A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance , 2012, BMJ Open.

[12]  Shane S. Sturrock,et al.  Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data , 2012, Bioinform..

[13]  Julian Parkhill,et al.  Whole genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing , 2012, Nature Genetics.

[14]  G. Weinstock,et al.  Making the Leap from Research Laboratory to Clinic: Challenges and Opportunities for Next-Generation Sequencing in Infectious Disease Diagnostics , 2015, mBio.

[15]  Didier Raoult,et al.  Bacterial genome sequencing and its use in infectious diseases. , 2007, The Lancet. Infectious diseases.

[16]  Elaine R. Mardis,et al.  A decade’s perspective on DNA sequencing technology , 2011, Nature.

[17]  O. Cars,et al.  Prevalence of hypermutators among clinical Acinetobacter baumannii isolates , 2015, The Journal of antimicrobial chemotherapy.

[18]  Bo Segerman,et al.  Gegenees: Fragmented Alignment of Multiple Genomes for Determining Phylogenomic Distances and Genetic Signatures Unique for Specified Target Groups , 2012, PloS one.

[19]  C. Robert,et al.  Rapid comparative genomic analysis for clinical microbiology: the Francisella tularensis paradigm. , 2008, Genome research.

[20]  W. M. Dunne,et al.  Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[21]  Julian Parkhill,et al.  Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. , 2012, The New England journal of medicine.

[22]  Yongxiang Zhang,et al.  Pan-genome sequence analysis using Panseq: an online tool for the rapid analysis of core and accessory genomic regions , 2010, BMC Bioinformatics.

[23]  M. Tolmasky,et al.  Aminoglycoside modifying enzymes. , 2010, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[24]  Eric S. Lander,et al.  Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011 , 2012, Proceedings of the National Academy of Sciences.

[25]  Nicholas J Loman,et al.  High-throughput sequencing and clinical microbiology: progress, opportunities and challenges. , 2010, Current opinion in microbiology.

[26]  J. Parkhill,et al.  Whole genome sequencing identifies zoonotic transmission of MRSA isolates with the novel mecA homologue mecC , 2013, EMBO molecular medicine.

[27]  W. Witte,et al.  High-level ciprofloxacin resistance among hospital-adapted Enterococcus faecium (CC17). , 2010, International journal of antimicrobial agents.

[28]  Tsuyoshi Sekizuka,et al.  Genomewide Screening for Novel Genetic Variations Associated with Ciprofloxacin Resistance in Bacillus anthracis , 2010, Antimicrobial Agents and Chemotherapy.

[29]  S. Rasmussen,et al.  Identification of acquired antimicrobial resistance genes , 2012, The Journal of antimicrobial chemotherapy.

[30]  A. Kasarskis,et al.  How Next-Generation Sequencing and Multiscale Data Analysis Will Transform Infectious Disease Management , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  J. Rolain,et al.  Investigation of antibiotic resistance in the genomic era of multidrug-resistant Gram-negative bacilli, especially Enterobacteriaceae, Pseudomonas and Acinetobacter , 2013, Expert review of anti-infective therapy.

[32]  Madhuri Hegde,et al.  Assessment of clinical analytical sensitivity and specificity of next-generation sequencing for detection of simple and complex mutations , 2013, BMC Genetics.

[33]  Daniel J. Wilson,et al.  Transforming clinical microbiology with bacterial genome sequencing , 2012, Nature Reviews Genetics.

[34]  N. Woodford,et al.  Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. , 2011, FEMS microbiology reviews.

[35]  M. Pirmohamed,et al.  Emergence and global spread of epidemic healthcare-associated Clostridium difficile , 2012, Nature Genetics.

[36]  Daniel J. Wilson,et al.  Prediction of Staphylococcus aureus Antimicrobial Resistance by Whole-Genome Sequencing , 2014, Journal of Clinical Microbiology.

[37]  Birgit Funke,et al.  College of American Pathologists' laboratory standards for next-generation sequencing clinical tests. , 2015, Archives of pathology & laboratory medicine.

[38]  F. de la Cruz,et al.  Genomic analysis of the emergence and evolution of multidrug resistance during a Klebsiella pneumoniae outbreak including carbapenem and colistin resistance. , 2014, The Journal of antimicrobial chemotherapy.

[39]  P. Caspers,et al.  Impact of Specific pbp5 Mutations on Expression of β-Lactam Resistance in Enterococcus faecium , 2004, Antimicrobial Agents and Chemotherapy.

[40]  Sharon J. Peacock,et al.  Whole-genome sequencing to control antimicrobial resistance , 2014, Trends in genetics : TIG.

[41]  F. Baquero,et al.  Global Spread of Vancomycin-resistantEnterococcus faeciumfrom Distinct Nosocomial Genetic Complex , 2005 .

[42]  M. Byrne,et al.  The aacA-aphD gentamicin and kanamycin resistance determinant of Tn4001 from Staphylococcus aureus: expression and nucleotide sequence analysis. , 1987, Journal of general microbiology.

[43]  Evan S Snitkin,et al.  Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing , 2012, Science Translational Medicine.

[44]  T. Dallman,et al.  Public Health Value of Next-Generation DNA Sequencing of Enterohemorrhagic Escherichia coli Isolates from an Outbreak , 2012, Journal of Clinical Microbiology.

[45]  Jens Stoye,et al.  Updating benchtop sequencing performance comparison , 2013, Nature Biotechnology.